119th Congress
H.R. 4299
Protecting Patient Access to Cancer and Complex Therapies Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Gregory F. Murphy(R-NC)
- Introduced
- Jul 7, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce; House Committee on Ways and Means
- Official text
- Introduced in House · Congress.gov page
Cosponsors (55)
Original cosponsors (2)
- Adam Gray (D-CA)
- Neal P. Dunn (R-FL)
Added later (53)
- Earl L. "Buddy" Carter (R-GA) · Jul 29, 2025
- John Joyce (R-PA) · Sep 4, 2025
- Carol D. Miller (R-WV) · Oct 8, 2025
- Andy Harris (R-MD) · Oct 24, 2025
- Thomas H. Kean, Jr. (R-NJ) · Oct 24, 2025
- David Kustoff (R-TN) · Oct 28, 2025
- Mariannette Miller-Meeks (R-IA) · Oct 28, 2025
- Max L. Miller (R-OH) · Oct 28, 2025
- Troy Balderson (R-OH) · Oct 31, 2025
- Mike Kennedy (R-UT) · Nov 12, 2025
- Brian K. Fitzpatrick (R-PA) · Dec 16, 2025
- Mike Kelly (R-PA) · Jan 8, 2026
- Donald G. Davis (D-NC) · Jan 12, 2026
- August Pfluger (R-TX) · Feb 2, 2026
- Blake D. Moore (R-UT) · Feb 2, 2026
- Thomas R. Suozzi (D-NY) · Feb 2, 2026
- Vicente Gonzalez (D-TX) · Feb 4, 2026
- Scott H. Peters (D-CA) · Apr 2, 2026
- Gus M. Bilirakis (R-FL) · Apr 9, 2026
- Henry Cuellar (D-TX) · Apr 9, 2026
- Lance Gooden (R-TX) · Apr 9, 2026
- Nathaniel Moran (R-TX) · Apr 9, 2026
- Jared Moskowitz (D-FL) · Apr 16, 2026
- Claudia Tenney (R-NY) · Apr 22, 2026
- Dan Crenshaw (R-TX) · Apr 27, 2026
- Eric Sorensen (D-IL) · Apr 27, 2026
- Mike Carey (R-OH) · Apr 27, 2026
- Pat Harrigan (R-NC) · Apr 29, 2026
- Darin LaHood (R-IL) · May 21, 2026
- Juan Ciscomani (R-AZ) · Jun 10, 2026
- Marc A. Veasey (D-TX) · Jun 18, 2026
- Aaron Bean (R-FL) · Jun 23, 2026
- Beth Van Duyne (R-TX) · Jun 25, 2026
- Josh Gottheimer (D-NJ) · Jul 14, 2026
- Kevin Hern (R-OK) · Jul 21, 2026
- Janelle S. Bynum (D-OR) · Jul 22, 2026
- Russell Fry (R-SC) · Jul 22, 2026
- Jefferson Van Drew (R-NJ) · Jul 30, 2026
- Nicole Malliotakis (R-NY) · Aug 20, 2026
- Richard McCormick (R-GA) · Aug 20, 2026
- Brian Babin (R-TX) · Sep 10, 2026
- Nicholas A. Langworthy (R-NY) · Sep 10, 2026
- Raul Ruiz (D-CA) · Sep 10, 2026
- Sharice Davids (D-KS) · Sep 14, 2026
- Jake Ellzey (R-TX) · Sep 24, 2026
- Randy K. Weber, Sr. (R-TX) · Sep 24, 2026
- Zoe Lofgren (D-CA) · Sep 24, 2026
- Herbert C. Conaway, Jr. (D-NJ) · Oct 5, 2026
- Mike Flood (R-NE) · Oct 5, 2026
- Sanford D. Bishop, Jr. (D-GA) · Oct 5, 2026
- Adelita S. Grijalva (D-AZ) · Oct 9, 2026
- Adrian Smith (R-NE) · Oct 9, 2026
- Mark Alford (R-MO) · Oct 9, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To amend title XVIII of the Social Security Act to provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation.
Latest action(Jul 7, 2025): Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Roll-call votes
No recorded votes on this bill.
Actions
- Jul 7, 2025 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - Jul 7, 2025
Introduced in House